Skip to content

Effect of Merged Exercise Versus Relaxation Techniques in Primary Dysmenorrhoea

Effect of Group of Merged Exercies Versus Relaxation Techniques on Primary Dysmenorrhoea

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07771582
Enrollment
40
Registered
2026-08-18
Start date
2025-02-12
Completion date
2026-05-01
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhoea

Keywords

Exercise, Women, Primary dysmenorrhoea, Relaxation

Brief summary

This study aims to evaluate the effect of aerobic exercises and relaxation techniques on pain severity, quality of life, and menstrual symptoms in females with primary dysmenorrhea. Participants will be randomly assigned to either an exercise and relaxation group or a control group. The intervention group will perform aerobic exercises and relaxation sessions for 12 weeks, while the control group will receive no intervention. Pain levels, quality of life, and menstrual symptoms will be assessed before and after the intervention period.

Interventions

BEHAVIORALExercise

A structured exercises program consists of , Adductor stretching ,Bridging exercise, sit up exercises

Astructured relaxation program consisting of Relaxation positure,yoga ,meditation

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion criteriteria: 1. All females will be diagnosed as having primary dysmenorrhea 2. All of them are virgin. 3. They have regular menstrual cycle (a menstrual duration of 3-8 days, with 21-35 days between each two successive menstrual cycles). 4. Their age will be ranged from 18 to 25 years old. 5. Their body mass index (BMI) will be ranged from 18 to 25 Kg/m2.

Exclusion criteria

1. a history of pelvic inflammatory disease. 2. myoma and tumors. 3. pelvic infection,. 4. ovarian cyst. 5. any gynecological disease. 6. any hormonal abnormality. 7. any psychological problem.

Design outcomes

Primary

MeasureTime frameDescription
Serum cortisol level at week 12Baseline and 8week after the interventionSerum cortisol levels will be measured from venous blood samples using a validated laboratory assay and reported in µg/dL (or nmol/L, depending on the laboratory). It will measured at baseline and after 12 weeks of the intervention.
The Menstrual Distress Questionnaire12 weeksThe Menstrual Distress Questionnaire will be used to assess menstrual distress. It assesses 8 factors covered by 47 items. These factors include pain, concentration, behavioral change, autonomic reaction, water retention, negative effect, arousal and control.It is four point rating scale from non as no pain to severe. Maximum score is 141 meaning severe pain and minimum score is 1 meaning very mild pain

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026